SCHEMBL14928719

SCHEMBL14928719

CC[C@@H](Cc1ccccc1)Nc1nc(Cl)c(C#N)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 4/20 0.42
▸ KHK P50053 1/20 0.40
▸ BCHE P06276 3/20 0.39
▸ NPSR1 Q6W5P4 3/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ SOS1 Q07889 1/20 0.39
▸ KDM4E B2RXH2 5/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ GAA P10253 2/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ CRHR1 P34998 1/20 0.34
▸ MAP3K8 P41279 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16164550 0.89 KHK (0.43) ACHEKHKBCHENPSR1CYP1A2
SCHEMBL14928416 0.89 KHK (0.43) ACHEKHKBCHENPSR1CYP1A2
SCHEMBL16169002 0.84 ACHE (0.44) ACHEKHKBCHENPSR1CYP1A2
SCHEMBL16164471 0.84 ACHE (0.39) ACHEKHKBCHENPSR1CYP1A2
SCHEMBL16165769 0.82 ACHE (0.40) ACHEKHKBCHENPSR1CYP1A2
SCHEMBL15081454 0.82 ACHE (0.40) ACHEKHKBCHENPSR1CYP1A2
SCHEMBL14928834 0.82 KHK (0.44) KHKNPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL14928858 0.81 KHK (0.43) KHKSOS1KDM4EALDH1A1GAA
SCHEMBL14928623 0.81 KHK (0.43) KHKSOS1KDM4EALDH1A1GAA
SCHEMBL14928839 0.80 KHK (0.43) KHKSOS1ALDH1A1POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051310-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2015-06-09 — — US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 — — US disclosed
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2014-10-16 — — US disclosed
US-8809371-B2 — — 2014-08-19 — — US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK ACHE 4592/4885KHK 2008/4885BCHE 4402/4885
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, BTK, NOX4 ACHE 3135/4885KHK 1750/4885BCHE 4487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback